pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 17·1 min read
save

Opinion: MAHA pushes psychiatric deprescribing agenda, reshaping mental-health language

Jul 17, 2026·read at STAT ↗Negative

Sunny Patel, an associate professor of psychiatry and pediatrics at Georgetown University, critiques the Mental Health Advocacy (MAHA) movement in a recent opinion piece. He notes her background with SAMHSA and the recent MAHA Institute summit focused on "overmedicalization."

At the summit, the health secretary announced a plan to promote psychiatric deprescribing, including SAMHSA studies of prescribing trends, Medicare guidance on clinician payment for tapering, webinars on holistic care, and a technical expert panel for further recommendations.

Patel argues that this language shift-terms like "wellness," "metabolic dysfunction," and "dependency crisis"-serves to embed a specific agenda while the underlying programs needed to address overprescribing are being weakened.

She warns that elevating deprescribing to a cultural default may become a clinical hazard, especially as substantive protections and solutions are dismantled rather than strengthened.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: MAHA is rewriting the vocabulary of American mental health care”

read at STAT ↗
1,394 words · retrieved Jul 17
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
SUNNY5National Institutes of Health
drugs
LITHIUM
topics
Psychiatry & CNS21Endocrinology & Metabolism9Schizophrenia3Major Depression2Drug Shortage

related stories

  • Sep 5Opinion: What STAT readers think about M.D. vs. D.O., AI in medicine, surrogacy, and moreSTAT
  • Jul 16Opinion: Medicaid and SNAP cuts are exacerbating the intertwined problems of hunger and mental illnessSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Apr 28Opinion: Why do discussions about ‘brain health’ ignore mental illness?STAT
  • Sep 25Federal judge rolls back landmark disability protectionsSTAT